Considerations for Choosing Between Newer Agents in R/R B-Cell ALL

0 reviews

Lisa Astor

Targeted Oncology

In the past 5 years, 3 new treatment options have emerged to treat patients with relapsed or refractory acute lymphoblastic leukemia, providing hope for patients with this disease, but also ...

Read more about this

I'm interested in this

Share with others

Write the first review

Join now
to leave a review or read peer reviews!

Resource tags
Show all tags


Visit Site

Share with others

I'm interested